Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
SCIPIO BIOSCIENCE
INTERNAL ADDRESS
ARC-EN-CIEL
*MAILING ADDRESS
17 rue de la Vanne
*CITY
Montrouge
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
France
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92120
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
société par actions simplifiée (sas)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
France
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
Chemicals for use in science; biological and chemical preparations for use in science; Chemical and biological reagents used in scientific
apparatus for chemical or biological analysis; chemical preparations for laboratory analysis, for use in science; Chemical, biochemical, biological and biotechnological preparations for scientific
purposes, other than for medical or veterinary use; molecules, biomolecules, reagents, enzymes, antibody fragments, antibodies, all intended for research, development and medical research
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
Downloadable and recorded computer software applications in the medical field for collecting, processing, monitoring, and analyzing cell data;
Downloadable and recorded computer software and mobile applications used in connected medical devices for collecting, processing, and analyzing cell data; Downloadable and recorded computer software
used for biological, chemical and medical analysis; Downloadable and recorded computer software used for medical diagnosis; Scientific, research, weighing, measuring, detecting, testing, inspection
apparatus and instruments for collecting, processing, monitoring, and analyzing cells, molecules, RNA, DNA; Chemistry apparatus and instruments, namely, research laboratory analyzers for measuring,
testing and analyzing blood and other bodily fluids; Testing apparatus, namely, testing sample collection equipment, namely, tubes for use in diagnostic testing, not for medical purposes; Diagnostic
apparatus, for the detection of gene expression, not for medical purposes; Observation instruments, namely, medical laboratory research instruments for gene expression, cell, molecule, DNA, and RNA
analysis; Laboratory robots
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
Medical and surgical devices and instruments, namely, devices for collecting, processing, monitoring and analyzing cells, molecules, DNA, and
RNA ; Testing apparatus for testing cells, molecules, DNA, and RNA for medical purposes; Diagnostic apparatus for medical purposes; robots for medical use
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
Scientific and technological services and research and design relating thereto in the field of gene expression; chemical analysis services;
Providing medical and scientific research information in the field of clinical trials; Biological research; Bacteriological research; Chemical research; Medical research; Scientific research;
Scientific laboratory services; Research and development of new products for others; biochemical research and development; research and development in the pharmaceutical, biomedical and
biotechnological fields; laboratory research, analysis, evaluation, development and clinical trial of therapeutic, preventive and diagnostic compositions and treatments; Conducting scientific and
medical research for third parties; Consulting services in the field of pharmaceutical research, chemistry, biotechnology; Custom synthesis of chemical substances for medical, scientific, and
technological applications; Chemical and biological development services for medical, scientific, and technological applications; Chemical and biological laboratory services; Conducting chemical and
biological analyses; Custom design and development of chemical reagents; Design, installation, updating, maintenance of computer software used in connected medical devices; Design, installation,
updating, maintenance of computer software used for biological, chemical and medical analysis; Design, installation, updating, maintenance of computer software used for medical diagnosis; Design,
installation, updating, maintenance of computer software in the medical field; Software as a service (SaaS) services featuring software for biological, chemical, medical analysis, and medical
diagnosis
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97560035
Filing Date:08/23/2022
To the Commissioner for Trademarks:
MARK: SCIPIO (Standard Characters, see mark)
The literal element of the mark consists of SCIPIO. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, SCIPIO BIOSCIENCE, a société par actions simplifiée (sas) legally organized under the laws of France, having an address of
ARC-EN-CIEL
17 rue de la Vanne
Montrouge 92120
France
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Chemicals for use in science; biological and chemical preparations for use in science; Chemical and biological reagents used in scientific apparatus for chemical or
biological analysis; chemical preparations for laboratory analysis, for use in science; Chemical, biochemical, biological and biotechnological preparations for scientific purposes, other than for
medical or veterinary use; molecules, biomolecules, reagents, enzymes, antibody fragments, antibodies, all intended for research, development and medical research
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on France application number 4850223, filed 03/08/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
France registration number 4850223, and/or proof of renewal, registered 08/05/2022 with a renewal date of __________ and an expiration date of __________, and translation thereof, if appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
International Class 009: Downloadable and recorded computer software applications in the medical field for collecting, processing, monitoring, and analyzing cell data; Downloadable and recorded
computer software and mobile applications used in connected medical devices for collecting, processing, and analyzing cell data; Downloadable and recorded computer software used for biological,
chemical and medical analysis; Downloadable and recorded computer software used for medical diagnosis; Scientific, research, weighing, measuring, detecting, testing, inspection apparatus and
instruments for collecting, processing, monitoring, and analyzing cells, molecules, RNA, DNA; Chemistry apparatus and instruments, namely, research laboratory analyzers for measuring, testing and
analyzing blood and other bodily fluids; Testing apparatus, namely, testing sample collection equipment, namely, tubes for use in diagnostic testing, not for medical purposes; Diagnostic apparatus,
for the detection of gene expression, not for medical purposes; Observation instruments, namely, medical laboratory research instruments for gene expression, cell, molecule, DNA, and RNA analysis;
Laboratory robots
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on France application number 4850223, filed 03/08/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
France registration number 4850223, and/or proof of renewal, registered 08/05/2022 with a renewal date of __________ and an expiration date of __________, and translation thereof, if appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
International Class 010: Medical and surgical devices and instruments, namely, devices for collecting, processing, monitoring and analyzing cells, molecules, DNA, and RNA ; Testing apparatus
for testing cells, molecules, DNA, and RNA for medical purposes; Diagnostic apparatus for medical purposes; robots for medical use
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on France application number 4850223, filed 03/08/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
France registration number 4850223, and/or proof of renewal, registered 08/05/2022 with a renewal date of __________ and an expiration date of __________, and translation thereof, if appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
International Class 042: Scientific and technological services and research and design relating thereto in the field of gene expression; chemical analysis services; Providing medical and
scientific research information in the field of clinical trials; Biological research; Bacteriological research; Chemical research; Medical research; Scientific research; Scientific laboratory
services; Research and development of new products for others; biochemical research and development; research and development in the pharmaceutical, biomedical and biotechnological fields; laboratory
research, analysis, evaluation, development and clinical trial of therapeutic, preventive and diagnostic compositions and treatments; Conducting scientific and medical research for third parties;
Consulting services in the field of pharmaceutical research, chemistry, biotechnology; Custom synthesis of chemical substances for medical, scientific, and technological applications; Chemical and
biological development services for medical, scientific, and technological applications; Chemical and biological laboratory services; Conducting chemical and biological analyses; Custom design and
development of chemical reagents; Design, installation, updating, maintenance of computer software used in connected medical devices; Design, installation, updating, maintenance of computer software
used for biological, chemical and medical analysis; Design, installation, updating, maintenance of computer software used for medical diagnosis; Design, installation, updating, maintenance of
computer software in the medical field; Software as a service (SaaS) services featuring software for biological, chemical, medical analysis, and medical diagnosis
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on France application number 4850223, filed 03/08/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
France registration number 4850223, and/or proof of renewal, registered 08/05/2022 with a renewal date of __________ and an expiration date of __________, and translation thereof, if appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
The owner's/holder's proposed attorney information: Pina Campagna. Pina Campagna of Carter, DeLuca and Farrell LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no.
XXX, is located at
576 Broad Hollow Rd.
Melville, New York 11747
United States
631-501-5700(phone)
6315013526(fax)
docket@carterdeluca.com
The docket/reference number is 2655-99.
Pina Campagna submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1400 has been submitted with the application, representing payment for 4 class(es).
Declaration
Declaration Signature
Signature: /Pina Campagna/ Date: 08/23/2022
Signatory's Name: Pina Campagna
Signatory's Position: Attorney of record, NY bar member
Signatory's Phone Number: 631-501-5700
Signature method: Signed directly within the form
Payment Sale Number: 97560035
Payment Accounting Date: 08/23/2022
Serial Number: 97560035
Internet Transmission Date: Tue Aug 23 11:21:30 ET 2022
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20220823112131906
667-97560035-820c5b546a24d6f349f312fd49b
9d9640f447feca71f68a32fff515b26af354ed5-
CC-21301267-20220823104309993790